North America represents one of the leading regions for rheumatoid arthritis treatment, supported by a high prevalence of autoimmune disorders, advanced healthcare systems, and significant investments in research and development. The region benefits from the presence of major pharmaceutical companies, increasing adoption of biologic and targeted therapies, and growing emphasis on early...